|Bid||11.10 x 0|
|Ask||11.11 x 0|
|Day's Range||10.36 - 11.30|
|52 Week Range||8.47 - 32.95|
|Beta (3Y Monthly)||3.68|
|PE Ratio (TTM)||15.51|
|Earnings Date||Nov. 12, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||13.17|
Hexo launched Original Stash, a value cannabis brand. Hexo's CEO stated that the company intends to educate consumers and "disrupt the illicit market."
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) today noted the separately announced AUD$20 million initial public offering of Cronos Australia Limited (“Cronos Australia”). Under the offering, Cronos Australia is expected to issue 40 million new shares at an offering price of AUD$0.50 per share (the “Cronos Australia IPO”) ahead of its planned listing on the Australian Securities Exchange in November 2019. Established in February 2018, Cronos Australia is a 50/50 joint venture between Cronos Group and NewSouthern Capital Pty Ltd., and is led by Rodney Cocks and Peter Righetti. The launch marked a significant milestone in Cronos Group’s commitment to advancing cannabis research and producing and distributing products and brands at a global scale.
Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.
Aphria (APHA), a Canada-based global cannabis company, will report its results for the first quarter of fiscal 2020 today after the market opens.
Cannabis stocks see dark clouds looming. The week ending on October 11 was disastrous for the sector. Hexo stock fell after it withdrew its fiscal 2020 outlook.
OrganiGram Holdings (OGI) received a “buy” rating from Jefferies on October 11. However, the investment firm lowered its price for the stock.
The cannabis industry is in turmoil, but companies with enough cash can capitalize on the pain. Find out why Cronos Group Inc (TSX:CRON)(NYSE:CRON) and one other pot stock are primed to win.
Both Green Organic Dutchman Holdings Ltd (TSX:GOD) and Cronos Group Inc (TSX:CRON)(NYSE:CRON) are set to grow sales rapidly, but one is a potential buy, while the other may face steep hurdles.
The cannabis sector continued its downward movement in the week that ended on October 10, with ETFs and prominent cannabis players falling.
Cronos Group Inc. (CRON.TO) (CRON.TO) (“Cronos Group” or the “Company”) will announce its financial results for the third quarter ended September 31, 2019 and hold its Third Quarter 2019 Earnings Conference Call on Tuesday, November 12, 2019 at 8:30 a.m. EDT. A live audio webcast of the earnings call will be available on the Company’s website at https://ir.thecronosgroup.com/events-presentations. The call will be archived on the Company’s website for replay.
On October 8, Piper Jaffray senior analyst Michael Lavery voiced his opinions about the impact of vaping on cannabis stocks in an interview.
Aphria is scheduled to report its earnings for the first quarter of fiscal 2020 on October 15. September wasn’t a good month for the cannabis industry.
Cannabis 2.0 will open up a massive expansion opportunity for cannabis companies. Many cannabis players are gearing up to leverage this opportunity.
At 1:40 PM ET, the S&P; 500 and the Dow Jones Industrial Average were up 0.2% and 0.3%, respectively. However, cannabis ETFs were trading in the red.
The stocks of major cannabis companies like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) are down by 50% or more. If you want to take advantage, here's what to buy.
Cannabis producer revenues could take a hit as pot shops shift from big initial orders fuelled by fears of shortages to smaller inventory purchases prioritizing brands consumers actually want to buy.